CPC A61K 31/7048 (2013.01) [A61K 9/2018 (2013.01); A61K 9/2866 (2013.01); A61K 31/7034 (2013.01)] | 24 Claims |
1. A method for improving glycemic control in a patient with type 2 diabetes mellitus comprising:
a) assessing the renal function of the patient; and
b) administering empagliflozin to the patient if the eGFR of the patient is
≥45 ml/min/1.73 m2 and <60 ml/min/1.73 m2,
wherein empagliflozin is administered orally in a total daily amount of 10 mg or 25 mg, and
wherein the glycemic control in said patient is improved.
|